NWF Advisory Services Inc.

Position in LLY — ELI LILLY & Co

CIK 2045735 Los Angeles, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,561,982

+$743,597 QoQ

Shares Held

2,136

+8.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#2,273

of 4,605 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NWF Advisory Services Inc. holds $14,660,430 across 10 Drug Manufacturers - General names. LLY ranks #2 (17.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	12,825	$3,227,283
2	LLY	ELI LILLY & Co This page	2,136	$2,561,982
3	JNJ	Johnson & Johnson	9,493	$2,410,937
4	AMGN	Amgen Inc	5,766	$2,087,983
5	MRK	Merck & Co., Inc.	14,785	$1,899,872
6	PFE	Pfizer Inc	38,937	$937,602
7	AZN	Astrazeneca PLC	3,332	$631,813
8	BMY	Bristol Myers Squibb Co	6,255	$360,413

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,561,982	2,136	+8.0%	Shares	Sole	2026-07-29
2026-03-31	$1,818,385	1,977	-4.3%	Shares	Sole	2026-05-04
2025-12-31	$2,220,289	2,066	+1.6%	Shares	Sole	2026-03-03
2025-09-30	$1,551,179	2,033	+3.0%	Shares	Sole	2025-10-31
2025-06-30	$1,538,792	1,974	+103.1%	Shares	Sole	2025-09-09
2025-03-31	$802,784	972	+15.3%	Shares	Sole	2025-08-12
2024-12-31	$650,796	843	-52.7%	Shares	Sole	2025-05-14
2024-09-30	$1,580,516	1,784	+20.3%	Shares	Sole	2025-10-06
2024-06-30	$1,342,678	1,483	+16.1%	Shares	Sole	2025-10-06
2024-03-31	$993,454	1,277	+12.1%	Shares	Sole	2025-10-06
2023-12-31	$663,945	1,139	+1.2%	Shares	Sole	2025-12-08
2023-09-30	$604,808	1,126	-0.2%	Shares	Sole	2025-12-08
2023-06-30	$529,009	1,128	0.0%	Shares	Sole	2025-12-08
2023-03-31	$387,377	1,128	—	Shares	Sole	2025-12-08
No filing history on record for this holder in this stock.